A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00231829
Recruitment Status : Terminated (Due to reported toxicity of Celecoxib at high doses)
First Posted : October 4, 2005
Last Update Posted : April 24, 2012
Information provided by (Responsible Party):
Mark H. Einstein, Montefiore Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2004
  Actual Study Completion Date : March 2004